|
Market Closed -
Deutsche Boerse AG
17:49:00 12/08/2026 +04
|
After hours 23:59:59 | |||
| 222.80 EUR | -1.20% |
|
222.40 | -0.18% |
| 08-11 | Berenberg Adjusts UCB Forecasts After H1 Beat; Buy Reaffirmed | MT |
| 08-11 | UCB barely moves despite positive calls from ING and Berenberg |  |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 79.58B | |||||
| 52.73B | |||||
| 49.77B | |||||
| 46.77B | - | ||||
| 30.13B |
- Stock Market
- Stocks
- UCB Stock
- UNC Stock
- Charts UCB
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
